Healthcare - Biotechnology - NASDAQ - DK
$ 1.44
-14.3 %
$ 8.16 M
Market Cap
-0.51
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
485.54%
EBIT
Estimate
44.19%
Net Income
Estimate
20.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evaxion Biotech A/S
EVAX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart EVAX
EBIT FORECAST
EBIT Forecast Chart EVAX
NET INCOME FORECAST
Net Income Chart EVAX